GlassScriptPhysician profile
Tania Carchi
NPI 1255976320
$927.52
in general payments reported to CMS, 2019-2025
14 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $232 · 2023: $127 · 2024: $170 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $216.99 | 2024-2025 | Rezdiffra, Resmetirom |
| Medtronic, INC. | $125.88 | 2025 | Signia |
| Takeda Pharmaceuticals U.S.A., INC. | $122.90 | 2022-2025 | Entyvio |
| Abbvie INC. | $108.64 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.62 | 2022-2024 | Xifaxan |
| Janssen Biotech, INC. | $48.45 | 2022-2024 | Simponi Aria, Simponi, Stelara |
| Qol Medical, LLC | $40.40 | 2022 | |
| Phathom Pharmaceuticals, INC. | $39.50 | 2024-2025 | Voquezna |
| Braintree Laboratories, INC. | $34.35 | 2022-2025 | Suflave |
| Redhill Biopharma INC. | $30.00 | 2023 | Movantik, Talicia, Aemcolo |
| Regeneron Healthcare Solutions, INC. | $25.84 | 2022 | |
| Ardelyx, INC. | $25.24 | 2025 | Ibsrela |
| Genzyme Corporation | $19.53 | 2024 | |
| Celgene Corporation | $15.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Carchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.